Paraneoplastic syndromes: An unsolved murder

Seminars in Pediatric Neurology

Volumn 7, Issue 2, 2000, Pages 118-130

  Pranzatelli, Michael R ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOTOXIC AGENT; IMMUNOGLOBULIN;

ARTICLE; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOADSORPTION; IMMUNOTHERAPY; NEUROIMMUNOLOGY; PARANEOPLASTIC SYNDROME; PLASMAPHERESIS;

EID: 0033917139     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1053/pb.2000.6695     Document Type: Article

References (87)

1. Schottenfeld D Epidemiology Abeloff MD Armitage JO Lichter AS Clinical Oncology 1995 Churchill Livingstone New York NY 315 337
2. John WJ Patchell RA Foon KA Paraneoplastic syndromes De Vita VT Hellman S Rosenberg SA Cancer: Principles & Practice of Oncology ed 5 1997 Lippincott-Raven Philadelphia, PA 2397 2422
3. Dalmau JO Posner JB Paraneoplastic syndromes affecting the nervous system Semin Oncol 24 1997 318 328
4. Pranzatelli MR The immunopharmacology of the opsoclonus-myoclonus syndrome Clin Neuropharmacol 19 1996 1 47
5. Okamura H Oomori N Uchitomi Y An acutely confused 15-year-old girl Lancet 350 1997 488
6. Pranzatelli MR The neurobiology of the opsoclonusmyoclonus syndrome Clin Neuropharmacol 15 1992 186 228
7. Hohlschneider AM Geiger H Bolkenius N Neuroblastoma: Paraneoplastic disease and late complications Monatsschr Kinderheilkd 125 1977 69 73
8. Schor NF Nervous system dysfunction in children with paraneoplastic syndromes J Child Neurol 7 1992 253 258
9. (abstr) Fisher PG Wechsler DS Singer HS Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome Ann Neurol 32 1992 446
10. Jean WC Dalmau J Ho A Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu associated paraneoplastic encephalomyelitis Neurology 44 1994 140 147
11. Shavit YB Graus F Probst A Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis Ann Neurol 45 1999 255 258
12. Hammack J Kimmel DW O'Neill BP Paraneoplastic cerebellar degeneration: A clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies Mayo Clinic Proc 65 1990 1423 1431
13. Voltz R Carpentier AF Rosenfeld MR P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system Muscle Nerve 22 1999 119 122
14. Adamus G Machnicki M Elerding H Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo J Autoimmun 11 1998 523 533
15. Khwaja S Sripathi N Ahmad BK Paraneoplastic motor neuron disease with type 1 Purkinje cell antibodies Muscle Nerve 21 1998 943 945
16. Ho TW McKhann GM Griffin JW Human autoimmune neuropathies Annu Rev Neurosci 21 1998 187 226
17. Vernino S Adamski J Kryzer TJ Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes Neurology 50 1998 1806 1813
18. Lee EK maselli RA Ellis WG Morvan's fibrillary chorea: A paraneoplastic manifestation of thymoma J Neurol Neurosurg Psyhiatry 65 1998 857 862
19. Lennon VA Serologic profile of myasthenia gravis and distinction from the Lambert-Eaton myasthenic syndrome Neurology 48 suppl 5 1997 S23 S27
20. Lovelace RE Younger DS Myasthenia gravis with thymoma Neurology 48 suppl 5 1997 S76 S81
21. Miller FW Leitman SF Cronnin ME Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis N Engl J Med 326 1992 1380 1384
22. Hall TC Paraneoplastic syndromes: Mechanisms Semin Oncol 24 1997 269 276
23. Ioannides CG Grimm EA Tumor immunity Rich R Fleisher TA Schwarrtz BJ Clinical Immunology: Principles and Practice 1996 Mosby St Louis, MO 333 349
24. Solomon GE Chutorian AM Opsoclonus and occult neuroblastoma N Engl J Med 279 1968 475 477
25. Brodeur GM Castleberry RP Neuroblastoma Pizzo PA Poplack DG Principles and Practive of Pediatric Oncology ed 3 1997 Lippincott-Raven Philadelphia, PA 761 797
26. Hochholzer L Moran CA Koss MN Primary pulmonary ganglioneuroblastoma: A clinicopathologic and immunohistochemical study of two cases Ann Diag Pathol 2 1998 154 158
27. Dropcho EJ Kline LB Riser J Antineuronal (Anti-Ri) antibodies in a patient with steroid-responsive opsoclonus myoclonus Neurology 43 1993 207 211
28. Ducrocq X Petit J Taillandier L Paraneoplastic opsoclonus-myoclonus syndrome revealing T-cell lymphoma Presse Med 28 1999 330 333
29. Altmann AJ Baehner RL Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma Cancer 37 1976 846 852
30. Everson TC Cole WH Spontaneous regression of neuroblastoma Everson TC Cole WH Spontaneous Regression of Cancer 1996 WB Saunders Philadelphia, PA
31. Furneaux HM Reich L Posner JB Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes Neurology 40 1990 1085 1091
32. Vega F Graus F Chen QM Intravenous (iv) immunoglobulin therapy in paraneoplastic neurologic syndromes (pns) with antineuronal antibodies Neurology 44 suppl 2 1994 157
33. Ziter FA Bray PF Cancilla PA Neuropathological findings in a patient with neuroblastoma and myoclonic encephalopathy Arch Neurol 36 1979 51
34. Giordana MT Soffietti R Schiffer D Paraneoplastic opsoclonus: A neuropathologic study of two cases Clin Neuropathol 8 1989 295 300
35. Tuchman RF Alvarez LA Kantrowitz AB Opsoclonus-myoclonus syndrome: Correlation of radiographic and pathological observations Neuroradiology 31 1989 250 252
36. Clerico A Tenore A Bartolozzi S Adrenocorticotropic hormone-secreting ganglioneuroblastoma associated with opsomyolonic encephalopathy: A case report with immunohistochemical study Med Pediatr Oncol 21 1993 690 694
37. Martin EF Beckwith JB Lymphoid infitrates in neuroblastoma: Their occurrence and prognostic significance J Pediatr Surg 3 1968 161 164
38. Barnett L Fujinami R Molecular mimicry: A mechanism for autoimmune injury FASEB J 6 1992 840 844
39. Albert ML Darnell JC Bender A Tumor-specific killer cells in paraneoplastic cerebellar degeneration Nat Med 4 1998 1321 1324
40. Gold R Hartung H-P Lassmann H T-cell apoptosis in autoimmune diseases: Termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms Trends Neurosci 20 1997 399 404
41. Adamus G Amundson D Seigel GM Anti-enolasealpha autoantibodies in cancer-associated retinopathy: Epitope mapping and cytotoxicity on retinal cells J Autoimmun 11 1998 671 677
42. Lindstrom JM Seybold ME Lennon VA Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value Neurology 26 1976 1054 1059
43. Antoine JC Absi L Honnorat J Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors Arch Neurol 56 1999 172 177
44. Saiz A Dalmau J Butler MH Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma J Neurol Neurosurg Psychiatry 66 1999 214 217
45. Arawaka S Daimon M Sasaki H A novel autoantibody in paraneoplastic sensory-dominant neuropathy reacts with brain-type creatine kinase Int J Mol Med 1 1998 597 600
46. Honnorat J Antoine JC Derrington E Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes J Neurol Neurosurg Psychiatry 61 1996 270 278
47. Szabo A Dalmau J Manley G HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to elav and sex-lethal Cell 67 1991 325 333
48. Hersh B Dalmau J Dangond F Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody Neurology 44 1994 1754 1755
49. Dalmau J Gultekin SH Voltz R Mal, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders Brain 122 1999 27 39
50. Newman LS McKeever MO Okano HJ β-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein Cell 82 1995 773 783
51. Noetzel M Cawley LP James VL Anti-neurofilament protein antibodies in opsoclonus-myoclonus J Neuroimmunol 15 1987 137 145
52. Connolly AM Pestronk A Mehta S Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: An analysis of antigenic targets in neural tissues J Pediatr 130 1997 878 884
53. Verschuuren JJ Dalmau J Tunkel R Antibodies against the calcium channel β-subunit in Lambert-Eaton myasthenic syndrome 50 1998 475 479
54. Ohguro H Ogawa K Nakagawa T Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy Invest Ophthalmol Vis Sci 40 1999 82 89
55. Buckanovich RJ Posner JB Darnell RB Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system Neuron 11 1993 657 672
56. Luque FA Furneaux HM Ferziger R Anti Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer Ann Neurol 29 1991 241 251
57. Yang YY Yin GL Darnell RB The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia Proc Natl Acad Sci USA 95 1998 13254 13259
58. Graus F Gultekin SH Ferrer I Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin's disease in the rat nervous system Acta Neuropathol 96 1998 1 7
59. + channels of peripheral nerves Ann Neurol 38 1995 714 722
60. Chen T-T Rettig W Yenamandra AK Cerebellar degeneration-related antigen: A highly conserved neuroectodermal marker mapped to chromosome X in human and mouse Proc Natl Acad Sci 87 1990 3077 3081
61. Peterson K Kotanides H Furneaux HM Anti-Yopositive paraneoplastic cerebellar degeneration: A clinical study of 51 patients Neurology 41 suppl 1 1991 362
62. Corradi Jp Yang C Darnell JC A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues J Neurosci 17 1997 1406 1415
63. Dalmau J Graus F Cheung H-kV Major histocompatibility (MHC) proteins anti-Hu antibodies and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer Cancer 75 1995 99 109
64. Plioplys AV Greaves A Yoshida W Anti-CNS antibodies in childhood neurologic diseases Neuropediatrics 20 1989 93 102
65. Tora M Graus F de Bolos C Cell surface expression of paraneoplatic encephalomyelitis/sensory neuronopathyassociated Hu antigens in small-cell lung cancers and neuroblastomas Neurology 48 1997 735 741
66. Lennon VA Paraneoplastic autoantibodies: The case for a descriptive generic nomenclature Neurology 44 1994 2236 2240
67. (editorial) Fathallah-Shaykh H Paraneoplastic neurological syndromes: Paraneoplastic or neurological? Arch Neurol 56 1999 151 152
68. Sodeyama N Ishida K Jaeckle KA Pattern of epitopic reactivity of the anti-Hu antibody on HuD with and without paraneoplastic syndrome J Neurol Neurosurg Psychiatry 66 1999 97 99
69. Benyahia B Liblau R Merle-Beral H Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies Ann Neurol 45 1999 162 167
70. Ichimura M Yamamoto M Kobayashi Y Tissue distribution of pathological lesions and Hu antigen expression in paraneoplastic sensory neuronopathy Acta Neuropathol 95 1998 641 648
71. (editorial) Jaeckle KA Autoimmunity in paraneoplastic neurological syndromes: Closer to the truth? Ann Neurol 45 1999 143 145
72. Stephenson JBP Graham-Pole J Ogg L Reactivity to neuroblastoma extracts in childhood cerebellar encephalopathy (“dancing eyes” syndrome) Lancet 2 1976 975 976
73. Bill AH Morgan A Evidence for immune reactions to neuroblastoma and future possibilities for investigation J Pediatr Surg 5 1970 111 116
74. Hellström IE Hellström KE Bill AH Studies on cellular immunity to human neuroblastoma cells Int J Cancer 6 1970 172 178
75. Sugie H Sugie Y Akimoto H High-dose iv human immunglobulin in a case with infantile opsoclonus polymyoclonia syndrome Acta paediatr 81 1992 371 372
76. Tanaka M Tanaka K Shinozawa K Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody J Neurol Sci 161 1998 88 90
77. Herishanu Y Apte R Kuperman O Immunologic abnormalities in opsoclonus cerebellopathy Neuro-Opthalmology 5 1985 271 275
78. Kinsbourne M Myoclonic encephalopathy of infants J Neurol Neurosurg Psychiatry 25 1962 271 276
79. Pranzatelli MR Huang Y-y Tate E Monoaminergic effects of high-dose corticotrophin in corticotrophin-responsive pediatric opsoclonus-myoclonus Mov Disord 13 1998 522 528
80. Faris M Abraham J Barrett-Lee P A patient with breast cancer and paraneoplastic cerebellar syndrome associated with anti-Purkinje cell antibodies: Response to CMF chemotherapy Clin Oncol 10 1998 202 203
81. (abstr) Edmondson JC Nichter CA Selman JE Use of intravenous gamma globulin therapy for postinfectious acute cerebellar ataxia/opsoclonus of childhood Ann Neurol 32 1992 440
82. (letter) Recht L Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration J Neurol Neurosurg Psychiatry 56 1993 1338
83. Counsell CE McLeod M Graut R Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin Neurology 44 1994 1184 1185
84. Cocconi G Ceci G Juvarra G Successful treatment of subacute cerebellar degeneration in ovarian carcinoma with plasmapheresis: A case report Cancer 56 1985 2318 2320
85. Graus F Vega F Delattre JY Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies Neurology 42 1992 536 540
86. Ciavarella D The use of protein A columns in the treatment of cancer and allied diseases Int J Clin Lab Res 21 1992 210 213
87. Batchelor TT Platten M Hochberg FH Immunoadsorption therapy for paraneoplastic syndromes J Neurooncol 40 1998 131 136